These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8831598)

  • 41. Lipoprotein abnormalities in two children with minimal biliary excretion.
    Levy E; Bendayan M; Thibault L; Lambert M; Paradis K
    J Pediatr Gastroenterol Nutr; 1995 May; 20(4):432-9. PubMed ID: 7636686
    [No Abstract]   [Full Text] [Related]  

  • 42. Hypercholesterolemia Due to Lipoprotein X: Case Report and Thematic Review.
    Kattah L; Gómez A; Gutiérrez S; Puerto K; Moreno-Pallares ED; Jaramillo A; Mendivil CO
    Clin Med Insights Endocrinol Diabetes; 2019; 12():1179551419878687. PubMed ID: 31632171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fatty acid content in lymphocytes from children with syndromic paucity of interlobular bile ducts, Alagille syndrome.
    Pina P; Couturier M; Lemonnier F
    J Inherit Metab Dis; 1995; 18(6):727-36. PubMed ID: 8750612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diseases of bile duct in children.
    Eiamkulbutr S; Tubjareon C; Sanpavat A; Phewplung T; Srisan N; Sintusek P
    World J Gastroenterol; 2024 Mar; 30(9):1043-1072. PubMed ID: 38577180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis.
    Colantuono R; Pavanello C; Pietrobattista A; Turri M; Francalanci P; Spada M; Vajro P; Calabresi L; Mandato C
    Front Pediatr; 2022; 10():969081. PubMed ID: 35989999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Case of Infantile Alagille Syndrome With Severe Dyslipidemia: New Insight into Lipid Metabolism and Therapeutics.
    Nakajima H; Tsuma Y; Fukuhara S; Kodo K
    J Endocr Soc; 2022 Mar; 6(3):bvac005. PubMed ID: 35155971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LCAT protects against Lipoprotein-X formation in a murine model of drug-induced intrahepatic cholestasis.
    Amar MJA; Freeman LA; Nishida T; Sampson ML; Pryor M; Vaisman BL; Neufeld EB; Karathanasis SK; Remaley AT
    Pharmacol Res Perspect; 2020 Feb; 8(1):e00554. PubMed ID: 31893124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atherosclerosis causing recurrent catastrophic aortopulmonary shunt dehiscence in a patient with Alagille syndrome.
    May L; Hanley FL; Connolly AJ; Reddy S
    Pediatr Cardiol; 2013; 34(8):1945-8. PubMed ID: 22923029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bile composition in Alagille Syndrome and PFIC patients having Partial External Biliary Diversion.
    Emerick KM; Elias MS; Melin-Aldana H; Strautnieks S; Thompson RJ; Bull LN; Knisely As; Whitington PF; Green RM
    BMC Gastroenterol; 2008 Oct; 8():47. PubMed ID: 18937870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites.
    Sonoda J; Chong LW; Downes M; Barish GD; Coulter S; Liddle C; Lee CH; Evans RM
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2198-203. PubMed ID: 15671183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alagille syndrome.
    Hadchouel M
    Indian J Pediatr; 2002 Sep; 69(9):815-8. PubMed ID: 12420916
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of total parenteral nutrition with intravenous fat on lipids and high density lipoprotein heterogeneity in neonates.
    Forte TM; Genzel-Boroviczeny O; Austin MA; Kao LC; Scott C; Albers JJ; D'Harlingue AE
    JPEN J Parenter Enteral Nutr; 1989; 13(5):490-500. PubMed ID: 2514290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormal lipoprotein pattern in patients with Alagille syndrome depends on Icterus severity.
    Davit-Spraul A; Pourci ML; Atger V; Cambillau M; Hadchouel M; Moatti N; Legrand A
    Gastroenterology; 1996 Oct; 111(4):1023-32. PubMed ID: 8831598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipoprotein pattern and plasma lecithin cholesterol acyl transferase activity in children with Alagille syndrome.
    Gottrand F; Clavey V; Fruchart JC; Farriaux JP
    Atherosclerosis; 1995 Jun; 115(2):233-41. PubMed ID: 7661882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cholesterol efflux from Fu5AH cells to the serum of patients with Alagille syndrome. Importance of the hdl-phospholipids/free cholesterol ratio and of the hdl size distribution.
    Davit-Spraul A; Atger V; Pourci ML; Hadchouel M; Legrand A; Moatti N
    J Lipid Res; 1999 Feb; 40(2):328-35. PubMed ID: 9925663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma lecithin-cholesterol acyltransferase activity and plasma lipoprotein composition and concentrations in kwashiorkor.
    Dhansay MA; Benadé AJ; Donald PR
    Am J Clin Nutr; 1991 Feb; 53(2):512-9. PubMed ID: 1989419
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.